Stress cardiomyopathy laboratory findings

Stress cardiomyopathy Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Stress Cardiomyopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Unstable angina/non ST elevation myocardial infarction in Stress (Takotsubo) Cardiomyopathy
Future or Investigational Therapies
Case Studies
Case #1
Stress cardiomyopathy laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Stress cardiomyopathy laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Stress cardiomyopathy laboratory findings
CDC on Stress cardiomyopathy laboratory findings
Stress cardiomyopathy laboratory findings in the news
Blogs on Stress cardiomyopathy laboratory findings
Directions to Hospitals Treating Stress cardiomyopathy
Risk calculators and risk factors for Stress cardiomyopathy laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

Biomarker Studies

Cardiac biomarkers of myonecrosis, especially troponin, are invariably elevated.